mycophenolic acid glucuronide

Known as: MPAG cpd 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1972-2014
024619722014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
BACKGROUND Promising data regarding the safety and efficacy of gastric bypass surgery (GBS) as an option to address obesity in… (More)
Is this relevant?
2005
2005
AIMS The pharmacokinetics of mycophenolic acid and its glucuronide are complex. This study investigated the pharmacokinetics… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The onset of diarrhea after the administration of mycophenolate mofetil (MMF) is possibly associated with the biliary excretion… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2004
2004
Mycophenolic acid (MPA), the active metabolite of the prodrug mycophenolate mofetil is an immunosuppressive agent which inhibits… (More)
Is this relevant?
2002
2002
Determinants of the wide interindividual variability of the pharmacokinetics of mycophenolic acid (MPA) in 21 stable pediatric… (More)
Is this relevant?
2002
2002
The acyl glucuronide metabolite (AcMPAG) of mycophenolic acid (MPA) has been found to possess both immunosuppressive and pro… (More)
Is this relevant?
1999
1999
A reversed-phase high-performance liquid chromatographic method for the simultaneous determination of mycophenolic acid and its… (More)
Is this relevant?
1999
1999
BACKGROUND Mycophenolic acid kinetics have been reported to vary after renal transplantation, and mycophenolic acid area under… (More)
Is this relevant?
1997
1997
Mycophenolic acid glucuronide (MPAG) inhibition kinetics were evaluated using purified recombinant human type II inosine… (More)
Is this relevant?
1997
1997
Inosine 5'-monophosphate dehydrogenase (IMP-DH) activities were measured in human lymphocytes (exhibiting type I IMP-DH activity… (More)
  • table 2
  • table 3
  • table 4
  • table 5
  • figure 1
Is this relevant?